{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:04:18Z","timestamp":1789560258981,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euf.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:18:46Z","timestamp":1789557526000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro)"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-5710","authenticated-orcid":false,"given":"Sigrid V.","family":"Carlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2026.09.001_b0005","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening- 23-year follow-up","volume":"393","author":"Roobol","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2026.09.001_b0010","article-title":"Prostate-specific antigen (PSA) test for prostate cancer screening","volume":"5","author":"Franco","year":"2026","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2026.09.001_b0015","doi-asserted-by":"crossref","unstructured":"Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of prostate cancer screening with prostate-specific antigen testing on long-term prostate cancer-specific mortality: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2026.04.005.","DOI":"10.1016\/j.eururo.2026.04.005"},{"key":"10.1016\/j.euf.2026.09.001_b0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2024.04.030","article-title":"Risk-adjusted screening for prostate cancer- defining the low-risk group by data from the PROBASE trial","volume":"86","author":"Krilaviciute","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.09.001_b0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071082","article-title":"Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit","volume":"381","author":"Vickers","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2026.09.001_b0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.euo.2023.09.008","article-title":"Digital rectal examination is not a useful screening test for prostate cancer","volume":"6","author":"Krilaviciute","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2026.09.001_b0035","doi-asserted-by":"crossref","unstructured":"Vickers AJ, Kasivisvanathan V, Brentnall AR. Effect of implementing population-based prostate-specific antigen screening on testing rates and prostate cancer overdiagnosis in England: a statistical modelling study. medRxiv. 2026. doi:10.64898\/2026.01.23.26344710.","DOI":"10.64898\/2026.01.23.26344710"},{"key":"10.1016\/j.euf.2026.09.001_b0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.euf.2025.09.003","article-title":"Socioeconomic status and prostate-specific antigen testing: a population-based cohort study comparing organised and opportunistic prostate cancer testing","volume":"12","author":"Arvendell","year":"2026","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2026.09.001_b0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.euros.2024.09.003","article-title":"Risk-stratified approach to implementing population-based prostate cancer screening in five pilot sites in the European Union: a protocol for the PRAISE-U project","volume":"70","author":"Chandran","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euf.2026.09.001_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2340\/sju.v60.43809","article-title":"Swedish regional population-based organised prostate cancer testing: why, what and how?","volume":"60","author":"Bratt","year":"2025","journal-title":"Scand J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926001975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926001975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:18:49Z","timestamp":1789557529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926001975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"alternative-id":["S2405456926001975"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.09.001","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro)","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}